The Business Research Company’s report on the Nerve Entrapment Syndrome Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the nerve entrapment syndrome market further?
The rising pool of diabetic patients is expected to propel the growth of the nerve entrapment syndrome market going forward. Diabetic patients are individuals with chronic conditions where the body cannot properly regulate blood sugar levels due to insufficient insulin production or ineffective insulin use. The growing number of diabetic patients is due to the increasing prevalence of obesity, and sedentary lifestyles significantly contribute to the rise in type 2 diabetes. The ever increasing number of diabetic patients raises the risk of nerve entrapment syndrome, as diabetes-induced peripheral neuropathy weakens nerves and surrounding structures, making them more prone to compression. For instance, in June 2024, according to the National Health Service, a UK-based government department, over half a million individuals (549,000) in England were identified as being at risk of developing type 2 diabetes in 2023, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330. This marks a nearly 20% increase compared to the 3,065,825 individuals in 2022. Therefore, the rising pool of diabetic patients is driving the growth of the nerve entrapment syndrome market.
Rising Obesity Rates Driving Growth In The Market Due To Increasing Pressure On Nerves
The increasing obese population is expected to propel the growth of the nerve entrapment syndrome market going forward. The obese population refers to individuals with a body mass index (BMI) of 30 or higher, indicating a level of body fat significantly above what is considered healthy for most people. The increasing obese population is due to factors such as poor diet, lack of physical activity, and environmental influences that promote sedentary lifestyles and unhealthy eating habits. Nerve entrapment syndrome can be more common in the obese population due to excess weight putting pressure on nerves. For instance, in May 2024, according to the Office for Health Improvement and Disparities (OHID), a UK-based Department of Health and Social Care (DHSC), around 26.2% of adults were living with obesity in 2022-2023, an increase from 25.9% in 2021-2022. Therefore, the increasing obese population is driving the growth of the nerve entrapment syndrome market.
Increasing Healthcare Expenditure Driving Growth In The Market By Enhancing Diagnosis And Treatment Options
The increasing healthcare expenditure is expected to propel the growth of the nerve entrapment syndrome market going forward. Healthcare expenditure is the total amount of financial resources spent on healthcare services by governments, private entities, and individuals, including prevention, treatment, and management of diseases. The increasing healthcare expenditure is due to the rising prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and obesity, which require ongoing treatment and management, leading to higher healthcare costs. Higher healthcare spending improves nerve entrapment syndrome management by enhancing diagnostics, specialized care, and minimally invasive treatments. It also advances surgical techniques, physiotherapy, and pain management, ensuring better recovery and outcomes. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure grew by 5.6% in nominal terms from 2022 to 2023, a rise compared to the 0.9% growth in 2022. Therefore, the increasing healthcare expenditure is driving the growth of the nerve entrapment syndrome market.
Access Your Free Sample of the Global Nerve Entrapment Syndrome Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=22069&type=smp
What are the key factors influencing the forecasted market size of the nerve entrapment syndrome industry?
The nerve entrapment syndrome market size has grown strongly in recent years. It will grow from $4.03 billion in 2024 to $4.34 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to the increasing prevalence of peripheral neuropathy, the growing prevalence of diabetes, the increasing geriatric population, the increasing obese population, and the rising incidence of chronic diseases.
The nerve entrapment syndrome market size is expected to see strong growth in the next few years. It will grow to $5.77 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to the increasing aging population, rising global incidence of peripheral nerve injuries (PNI), growing government initiatives and reimbursement policies, increasing number of traumatic injuries, and rising pool of diabetic patients. Major trends in the forecast period include development in R&D to expand product lines, advances in minimally invasive surgical procedures, development in regenerative medicine, enhanced imaging techniques, physical therapy and rehabilitation innovations, ongoing genetic research and personalized medicine.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=22069&type=smp
Who are the leading competitors in the nerve entrapment syndrome market?
Major companies operating in the nerve entrapment syndrome market are Pfizer Inc., Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Athletico Physical Therapy, Hinge Health, Kessler Rehabilitation Center, SPR Therapeutics, Centaur Pharmaceuticals, ProActive Physical Therapy & Rehabilitation, Care24 Pvt Ltd., Grünenthal GmbH, Total Performance Physical Therapy, Back 2 Health, Cornerstone Physical Therapy, OrthoSport Physical Therapy & Rehabilitation, Physio Tattva, InvaGen Pharmaceuticals Inc., WEX Pharmaceuticals Inc., Dogwood Therapeutics Inc., Endo Spine Clinic
How do different geographies compare in terms of market share and growth potential in the nerve entrapment syndrome market?
North America was the largest region in the nerve entrapment syndrome market in 2024. The regions covered in the nerve entrapment syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/nerve-entrapment-syndrome-global-market-report
Which major segments of the nerve entrapment syndrome market are experiencing the fastest growth?
The nerve entrapment syndrome market covered in this report is segmented –
1) By Type: Carpal Tunnel Syndrome, Cubital Tunnel Syndrome, Tarsal Tunnel Syndrome, Meralgia Parasthetica, Other Types
2) By Treatment Modality: Medications, Physical Therapy, Interventional Procedures, Alteative Therapies
3) By Administration Route: Oral Administration, Injectable Administration, Topical Administration
4) By Severity Of Condition: Mild, Moderate, Severe, Post-Surgical Complications
Subsegments:
1) By Carpal Tunnel Syndrome (CTS): Idiopathic Carpal Tunnel Syndrome, Work-Related/Repetitive Strain CTS, Diabetic Neuropathy-Associated CTS, Traumatic or Post-Surgical CTS, Pregnancy-Induced CTS
2) By Cubital Tunnel Syndrome: Idiopathic Cubital Tunnel Syndrome, Repetitive Motion-Induced Cubital Tunnel Syndrome, Post-Traumatic/Ulnar Nerve Injury-Related Cubital Tunnel Syndrome, Osteoarthritis-Related Cubital Tunnel Syndrome, Post-Surgical Cubital Tunnel Syndrome
3) By Tarsal Tunnel Syndrome (TTS): Idiopathic Tarsal Tunnel Syndrome, Trauma-Induced Tarsal Tunnel Syndrome, Diabetes-Associated Tarsal Tunnel Syndrome, Flatfoot-Related Tarsal Tunnel Syndrome, Post-Surgical Or Scar Tissue-Related TTS
4) By Meralgia Paresthetica (MP): Idiopathic Meralgia Paresthetica, Obesity-Associated Meralgia Paresthetica, Pregnancy-Related Meralgia Paresthetica, Post-Surgical Or Scar-Induced Meralgia Paresthetica, Diabetic Neuropathy-Related Meralgia Paresthetica
5) By Other Types: Radial Tunnel Syndrome, Thoracic Outlet Syndrome, Peroneal Nerve Entrapment, Sciatic Nerve Entrapment, Brachial Plexus Compression Syndromes
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22069
How is the nerve entrapment syndrome market defined, and what are its core characteristics?
Nerve entrapment syndrome refers to a condition in which a nerve is compressed or pinched, leading to pain, numbness, tingling, or weakness along the path of the affected nerve. This compression occurs at various points in the body where nerves pass through narrow spaces, such as joints, muscles, or ligaments.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
